The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.10
Bid: 33.00
Ask: 33.20
Change: 0.00 (0.00%)
Spread: 0.20 (0.606%)
Open: 33.10
High: 33.10
Low: 33.10
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further direct investment into Netacea

18 Oct 2023 07:00

RNS Number : 4392Q
Mercia Asset Management PLC
18 October 2023

18 October 2023

Mercia Asset Management PLC

("Mercia" the "Company" or the "Group")

Further direct investment into Netacea

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£1.4billion of assets under management, is pleased to announce completion of a £4.4million funding round* into Netacea Group Limited ("Netacea"), a Manchester-based cybersecurity business.

Mercia now holds a fully diluted 34.2% direct investment stake in Netacea, with its managed funds holding a further 31.2%. Mercia contributed £1.6 million to this funding round as part of its direct investment holding, with the remainder of the funds coming from the Mercia-managed Northern VCTs; Northern Powerhouse Investment Fund; and Netacea's management team.

This latest funding round will underpin Netacea's commercial progress as a leading provider of defensive AI software against bot attacks that target mobile, web and API applications, by supporting its continuing growth plans both in the UK and internationally. From its North West base, Netacea already supports some of the world's largest global retailers and telecommunications networks.

Dr Mark Payton, CEO of Mercia Asset Management PLC, commented: "Our continuing support reaffirms Mercia's belief in both Netacea's technology and the growth potential of the defensive AI software market. Investing in this Manchester-based business also underscores Mercia's continuing commitment to supporting game-changing businesses based across the UK."

Keira Shepperson, Director at British Business Bank, said: "This investment alongside Mercia demonstrates the transformational impact that the Northern Powerhouse Investment Fund has on the businesses it supports and the wider business community, helping to facilitate knowledge-sharing and building new bridges and connections."

*The funding round was achieved across two tranches, completed in July and October 2023.

-Ends-

For further information, please contact:

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

+44 (0)330 223 1430

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel

Singer Capital Markets (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

+44 (0)20 3727 1051

Tom Blackwell, Jenny Boyd

mercia@fticonsulting.com

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

The Group has a strong UK footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCGPGAAUUPWGQM
Date   Source Headline
9th Dec 20192:05 pmRNSSecond Price Monitoring Extn
9th Dec 20192:00 pmRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSPosting of documents and Notice of GM
3rd Dec 20193:46 pmRNSResult of Accelerated Bookbuild to raise £30.0m
3rd Dec 20199:05 amRNSSecond Price Monitoring Extn
3rd Dec 20199:00 amRNSPrice Monitoring Extension
3rd Dec 20197:01 amRNSProposed Acquisition & ABB to raise £30.0million
3rd Dec 20197:00 amRNSHalf Year Results
20th Nov 20197:00 amRNSnDreams makes significant commercial progress
14th Nov 20197:00 amRNSAppointment of Joint Broker
5th Nov 201911:02 amRNSNotification of Major Holdings
4th Nov 20194:49 pmRNSNotification of Major Holdings
1st Nov 20194:31 pmRNSNotification of Major Holdings
22nd Oct 20194:54 pmRNSNotification of Major Holdings
17th Oct 20191:59 pmRNSNotification of Major Holdings
16th Oct 20197:36 amRNSNotification of Major Holdings
25th Sep 20197:00 amRNSAnnouncement of significant contract for OXGENE
24th Sep 201911:02 amRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
10th Sep 20197:00 amRNS£7.5million syndicated investment into Voxpopme
1st Aug 20197:00 amRNSGrant of Options
29th Jul 20192:24 pmRNSNotification of Major Holdings
26th Jul 20197:00 amRNSPublication of Annual Report
8th Jul 20197:00 amRNSPreliminary Results
5th Jul 201910:00 amRNSChange of Name
2nd Jul 20197:00 amRNSDirectorate Change
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.